Related Experiment Videos
Lymphnodal metastases from unknown primary tumors
Neoplasma
|January 1, 1982
Summary
Diagnosing and treating lymph node metastases from unknown primary tumors remains challenging. This study found no clear correlation between histology, therapy, or survival in 71 patients, highlighting the need for further research.
Area of Science:
- Oncology
- Pathology
Background:
- Lymph node metastases of unknown origin present diagnostic and therapeutic challenges.
- The prognosis and optimal treatment strategies for these cases are not well-defined.
Purpose of the Study:
- To analyze the clinical characteristics, histological types, and treatment outcomes of patients with lymph node metastases from unknown primary tumors.
- To investigate potential correlations between histological type, lymph node site, therapy, and patient survival.
Main Methods:
- Retrospective analysis of 71 patients hospitalized between 1965 and 1979 with neoplastic adenopathies of unknown origin.
- Review of patient demographics, lymph node locations, histological diagnoses, and treatment modalities (surgery, chemotherapy, radiotherapy).
Main Results:
- Laterocervical adenopathies were most frequent; squamous cell carcinoma was the predominant histological type.
- The primary tumor was identified in only 11 cases; the remaining 60 had unknown primary sites.
- No significant correlation was found between histological type, lymph node site, therapy, or survival. 58.3% of patients died within 18 months.
Conclusions:
- The natural history of lymph node metastases from unknown primary tumors is unclear.
- Current combined therapies show no clear benefit in improving survival for these patients.
- Further research is needed to establish effective therapeutic strategies for this patient group.